ID NLGN3_MOUSE Reviewed; 825 AA. AC Q8BYM5; A2AGI1; Q8BXR4; DT 23-MAY-2003, integrated into UniProtKB/Swiss-Prot. DT 27-JUL-2011, sequence version 2. DT 24-JAN-2024, entry version 174. DE RecName: Full=Neuroligin-3; DE AltName: Full=Gliotactin homolog; DE Flags: Precursor; GN Name=Nlgn3; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Hypothalamus, and Retina; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [3] RP TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE. RX PubMed=11329178; DOI=10.1002/glia.1050; RA Gilbert M., Smith J., Roskams A.J., Auld V.J.; RT "Neuroligin 3 is a vertebrate gliotactin expressed in the olfactory RT ensheathing glia, a growth-promoting class of macroglia."; RL Glia 34:151-164(2001). RN [4] RP DISRUPTION PHENOTYPE, FUNCTION, AND TISSUE SPECIFICITY. RX PubMed=16982420; DOI=10.1016/j.neuron.2006.09.003; RA Varoqueaux F., Aramuni G., Rawson R.L., Mohrmann R., Missler M., RA Gottmann K., Zhang W., Sudhof T.C., Brose N.; RT "Neuroligins determine synapse maturation and function."; RL Neuron 51:741-754(2006). RN [5] RP INTERACTION WITH NLGN1 AND NLGN2, SUBUNIT, SUBCELLULAR LOCATION, AND TISSUE RP SPECIFICITY. RX PubMed=17897391; DOI=10.1111/j.1460-9568.2007.05842.x; RA Budreck E.C., Scheiffele P.; RT "Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic RT synapses."; RL Eur. J. Neurosci. 26:1738-1748(2007). RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-769, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain; RX PubMed=18034455; DOI=10.1021/pr0701254; RA Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.; RT "Large-scale identification and evolution indexing of tyrosine RT phosphorylation sites from murine brain."; RL J. Proteome Res. 7:311-318(2008). RN [7] RP TISSUE SPECIFICITY. RX PubMed=18434543; DOI=10.1073/pnas.0801383105; RA Bolliger M.F., Pei J., Maxeiner S., Boucard A.A., Grishin N.V., RA Sudhof T.C.; RT "Unusually rapid evolution of neuroligin-4 in mice."; RL Proc. Natl. Acad. Sci. U.S.A. 105:6421-6426(2008). RN [8] RP DISRUPTION PHENOTYPE. RX PubMed=19243448; DOI=10.1111/j.1601-183x.2009.00487.x; RA Radyushkin K., Hammerschmidt K., Boretius S., Varoqueaux F., El-Kordi A., RA Ronnenberg A., Winter D., Frahm J., Fischer J., Brose N., Ehrenreich H.; RT "Neuroligin-3-deficient mice: model of a monogenic heritable form of autism RT with an olfactory deficit."; RL Genes Brain Behav. 8:416-425(2009). RN [9] RP TISSUE SPECIFICITY. RX PubMed=19926856; DOI=10.1073/pnas.0809510106; RA Bottos A., Destro E., Rissone A., Graziano S., Cordara G., Assenzio B., RA Cera M.R., Mascia L., Bussolino F., Arese M.; RT "The synaptic proteins neurexins and neuroligins are widely expressed in RT the vascular system and contribute to its functions."; RL Proc. Natl. Acad. Sci. U.S.A. 106:20782-20787(2009). RN [10] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [11] RP FUNCTION, INTERACTION WITH NEUREXINS, AND MUTAGENESIS OF 586-LYS--ARG-590. RX PubMed=30100184; DOI=10.1016/j.cell.2018.07.002; RA Zhang P., Lu H., Peixoto R.T., Pines M.K., Ge Y., Oku S., Siddiqui T.J., RA Xie Y., Wu W., Archer-Hartmann S., Yoshida K., Tanaka K.F., Aricescu A.R., RA Azadi P., Gordon M.D., Sabatini B.L., Wong R.O.L., Craig A.M.; RT "Heparan Sulfate Organizes Neuronal Synapses through Neurexin RT Partnerships."; RL Cell 174:1450-1464(2018). CC -!- FUNCTION: Cell surface protein involved in cell-cell-interactions via CC its interactions with neurexin family members. Plays a role in synapse CC function and synaptic signal transmission, and probably mediates its CC effects by recruiting and clustering other synaptic proteins. May CC promote the initial formation of synapses, but is not essential for CC this. May also play a role in glia-glia or glia-neuron interactions in CC the developing peripheral nervous system. {ECO:0000269|PubMed:16982420, CC ECO:0000269|PubMed:30100184}. CC -!- SUBUNIT: Homodimer, and heterodimer with NLGN1 and NLGN2 (By CC similarity). Interacts with neurexins NRXN1, NRXN2 and NRXN3 (By CC similarity). Interaction with neurexins is mediated by heparan sulfate CC glycan modification on neurexin (PubMed:30100184). Interacts (via its CC C-terminus) with DLG4/PSD-95 (via PDZ domain 3) (By similarity). CC {ECO:0000250|UniProtKB:Q62889, ECO:0000269|PubMed:30100184}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17897391}; CC Single-pass type I membrane protein {ECO:0000269|PubMed:17897391}. CC Synapse {ECO:0000269|PubMed:17897391}. Note=Detected at both CC glutamatergic and GABAergic synapses. CC -!- TISSUE SPECIFICITY: Brain and arteries (at protein level). Detected in CC heart, brain, spleen, lung, liver, skeletal muscle, kidney and testis. CC Expressed in olfactory bulb and olfactory epithelium. Found in CC olfactory ensheathing glia but not in olfactory neurons, and in CC developing peripheral glia. {ECO:0000269|PubMed:11329178, CC ECO:0000269|PubMed:16982420, ECO:0000269|PubMed:17897391, CC ECO:0000269|PubMed:18434543, ECO:0000269|PubMed:19926856}. CC -!- DEVELOPMENTAL STAGE: Detected at embryonic day 17 dpc and postnatal day CC P1 in retinal astrocytes, spinal cord astrocytes and Schwann cells of CC the dorsal root ganglion. {ECO:0000269|PubMed:11329178}. CC -!- DISRUPTION PHENOTYPE: No obvious phenotype, but mice present subtle CC behavorial changes with reduced ultrasound vocalization and impaired CC response to olfactory cues. In addition, mice have reduced brain CC volume. Mice lacking both NLGN1 and NLGN3, or NLGN2 and NLGN3, are CC viable, but have impaired breathing, drastically reduced reproduction CC rates and striking deficits in raising their offspring. Mice lacking CC NLGN1, NLGN2 and NLGN3 are born at the expected Mendelian rate, but die CC shortly after birth due to respiratory failure. They do not show a CC significant change in the number of synapses, but synapse function is CC strongly impaired. {ECO:0000269|PubMed:16982420, CC ECO:0000269|PubMed:19243448}. CC -!- SIMILARITY: Belongs to the type-B carboxylesterase/lipase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK039018; BAC30207.1; -; mRNA. DR EMBL; AK044438; BAC31918.1; -; mRNA. DR EMBL; AL683892; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS30313.1; -. DR RefSeq; NP_766520.2; NM_172932.4. DR PDB; 7CEE; X-ray; 2.76 A; A/B=36-684. DR PDB; 7CEG; X-ray; 3.85 A; B=37-615. DR PDBsum; 7CEE; -. DR PDBsum; 7CEG; -. DR AlphaFoldDB; Q8BYM5; -. DR SMR; Q8BYM5; -. DR BioGRID; 232793; 7. DR IntAct; Q8BYM5; 3. DR MINT; Q8BYM5; -. DR STRING; 10090.ENSMUSP00000066304; -. DR ESTHER; mouse-3neur; Neuroligin. DR MEROPS; S09.987; -. DR GlyCosmos; Q8BYM5; 2 sites, No reported glycans. DR GlyGen; Q8BYM5; 3 sites, 1 O-linked glycan (1 site). DR iPTMnet; Q8BYM5; -. DR PhosphoSitePlus; Q8BYM5; -. DR SwissPalm; Q8BYM5; -. DR MaxQB; Q8BYM5; -. DR PaxDb; 10090-ENSMUSP00000066304; -. DR ProteomicsDB; 293575; -. DR ABCD; Q8BYM5; 1 sequenced antibody. DR Antibodypedia; 561; 345 antibodies from 37 providers. DR DNASU; 245537; -. DR Ensembl; ENSMUST00000065858.3; ENSMUSP00000066304.3; ENSMUSG00000031302.17. DR GeneID; 245537; -. DR KEGG; mmu:245537; -. DR UCSC; uc009txj.3; mouse. DR AGR; MGI:2444609; -. DR CTD; 54413; -. DR MGI; MGI:2444609; Nlgn3. DR VEuPathDB; HostDB:ENSMUSG00000031302; -. DR eggNOG; KOG1516; Eukaryota. DR GeneTree; ENSGT00940000159580; -. DR InParanoid; Q8BYM5; -. DR OMA; QCGHEGA; -. DR OrthoDB; 4386at2759; -. DR TreeFam; TF326187; -. DR Reactome; R-MMU-6794361; Neurexins and neuroligins. DR BioGRID-ORCS; 245537; 2 hits in 62 CRISPR screens. DR PRO; PR:Q8BYM5; -. DR Proteomes; UP000000589; Chromosome X. DR RNAct; Q8BYM5; Protein. DR Bgee; ENSMUSG00000031302; Expressed in dentate gyrus of hippocampal formation granule cell and 116 other cell types or tissues. DR ExpressionAtlas; Q8BYM5; baseline and differential. DR GO; GO:0009986; C:cell surface; ISS:BHF-UCL. DR GO; GO:0030139; C:endocytic vesicle; ISS:BHF-UCL. DR GO; GO:0060076; C:excitatory synapse; ISS:BHF-UCL. DR GO; GO:0098982; C:GABA-ergic synapse; ISO:MGI. DR GO; GO:0098978; C:glutamatergic synapse; ISO:MGI. DR GO; GO:0060077; C:inhibitory synapse; ISO:MGI. DR GO; GO:0043025; C:neuronal cell body; ISO:MGI. DR GO; GO:0045211; C:postsynaptic membrane; ISS:BHF-UCL. DR GO; GO:0099634; C:postsynaptic specialization membrane; ISO:MGI. DR GO; GO:0098793; C:presynapse; IEA:GOC. DR GO; GO:0045202; C:synapse; ISO:MGI. DR GO; GO:0050839; F:cell adhesion molecule binding; ISS:BHF-UCL. DR GO; GO:0042043; F:neurexin family protein binding; ISS:BHF-UCL. DR GO; GO:0097110; F:scaffold protein binding; ISO:MGI. DR GO; GO:0038023; F:signaling receptor activity; ISO:MGI. DR GO; GO:0030534; P:adult behavior; ISO:MGI. DR GO; GO:0048675; P:axon extension; ISS:BHF-UCL. DR GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central. DR GO; GO:0042745; P:circadian sleep/wake cycle; ISO:MGI. DR GO; GO:0060079; P:excitatory postsynaptic potential; IMP:BHF-UCL. DR GO; GO:0060080; P:inhibitory postsynaptic potential; IMP:BHF-UCL. DR GO; GO:0007612; P:learning; ISO:MGI. DR GO; GO:0060291; P:long-term synaptic potentiation; IMP:CACAO. DR GO; GO:0050804; P:modulation of chemical synaptic transmission; IGI:MGI. DR GO; GO:0061002; P:negative regulation of dendritic spine morphogenesis; IMP:CACAO. DR GO; GO:0090394; P:negative regulation of excitatory postsynaptic potential; IMP:CACAO. DR GO; GO:0007158; P:neuron cell-cell adhesion; ISS:BHF-UCL. DR GO; GO:0048709; P:oligodendrocyte differentiation; IMP:MGI. DR GO; GO:2000969; P:positive regulation of AMPA receptor activity; IMP:BHF-UCL. DR GO; GO:0060999; P:positive regulation of dendritic spine development; ISO:MGI. DR GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IMP:BHF-UCL. DR GO; GO:0097151; P:positive regulation of inhibitory postsynaptic potential; ISO:MGI. DR GO; GO:1902474; P:positive regulation of protein localization to synapse; ISO:MGI. DR GO; GO:0051965; P:positive regulation of synapse assembly; IMP:CACAO. DR GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IMP:BHF-UCL. DR GO; GO:2000809; P:positive regulation of synaptic vesicle clustering; IMP:CACAO. DR GO; GO:0097104; P:postsynaptic membrane assembly; IMP:BHF-UCL. DR GO; GO:0098698; P:postsynaptic specialization assembly; ISO:MGI. DR GO; GO:0060134; P:prepulse inhibition; ISO:MGI. DR GO; GO:0097105; P:presynaptic membrane assembly; ISS:BHF-UCL. DR GO; GO:0006898; P:receptor-mediated endocytosis; ISS:BHF-UCL. DR GO; GO:2000311; P:regulation of AMPA receptor activity; IMP:BHF-UCL. DR GO; GO:0061001; P:regulation of dendritic spine morphogenesis; IMP:BHF-UCL. DR GO; GO:1900271; P:regulation of long-term synaptic potentiation; IMP:BHF-UCL. DR GO; GO:2000310; P:regulation of NMDA receptor activity; IMP:BHF-UCL. DR GO; GO:0002087; P:regulation of respiratory gaseous exchange by nervous system process; IGI:MGI. DR GO; GO:0051966; P:regulation of synaptic transmission, glutamatergic; IMP:BHF-UCL. DR GO; GO:2000331; P:regulation of terminal button organization; IMP:BHF-UCL. DR GO; GO:0060024; P:rhythmic synaptic transmission; ISS:BHF-UCL. DR GO; GO:0035176; P:social behavior; IMP:BHF-UCL. DR GO; GO:0007416; P:synapse assembly; ISO:MGI. DR GO; GO:0050808; P:synapse organization; IGI:MGI. DR GO; GO:0048488; P:synaptic vesicle endocytosis; IBA:GO_Central. DR GO; GO:0008542; P:visual learning; IMP:MGI. DR GO; GO:0071625; P:vocalization behavior; ISO:MGI. DR Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1. DR InterPro; IPR029058; AB_hydrolase. DR InterPro; IPR002018; CarbesteraseB. DR InterPro; IPR019819; Carboxylesterase_B_CS. DR InterPro; IPR000460; Nlgn. DR PANTHER; PTHR43903; NEUROLIGIN; 1. DR PANTHER; PTHR43903:SF4; NEUROLIGIN-3; 1. DR Pfam; PF00135; COesterase; 1. DR PRINTS; PR01090; NEUROLIGIN. DR SUPFAM; SSF53474; alpha/beta-Hydrolases; 1. DR PROSITE; PS00941; CARBOXYLESTERASE_B_2; 1. DR Genevisible; Q8BYM5; MM. PE 1: Evidence at protein level; KW 3D-structure; Cell adhesion; Cell membrane; Disulfide bond; Glycoprotein; KW Membrane; Phosphoprotein; Reference proteome; Signal; Synapse; KW Transmembrane; Transmembrane helix. FT SIGNAL 1..34 FT /evidence="ECO:0000255" FT CHAIN 35..825 FT /note="Neuroligin-3" FT /id="PRO_0000008646" FT TOPO_DOM 35..686 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 687..707 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 708..825 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REGION 151..172 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 622..668 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 622..664 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 722 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q62889" FT MOD_RES 769 FT /note="Phosphotyrosine" FT /evidence="ECO:0007744|PubMed:18034455" FT CARBOHYD 95 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 522 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 103..138 FT /evidence="ECO:0000250" FT DISULFID 317..328 FT /evidence="ECO:0000250" FT DISULFID 487..521 FT /evidence="ECO:0000250" FT MUTAGEN 586..590 FT /note="KPRVR->APAVA: Reduced presynaptic differentiation." FT /evidence="ECO:0000269|PubMed:30100184" FT CONFLICT 64 FT /note="D -> E (in Ref. 1; BAC30207)" FT /evidence="ECO:0000305" FT CONFLICT 459 FT /note="Q -> K (in Ref. 1; BAC31918)" FT /evidence="ECO:0000305" FT STRAND 40..43 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 46..49 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 51..53 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 56..60 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 63..70 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 77..79 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 91..95 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 107..109 FT /evidence="ECO:0007829|PDB:7CEE" FT TURN 113..115 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 118..121 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 124..131 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 140..146 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 176..183 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 186..190 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 193..195 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 199..205 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 208..212 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 217..221 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 225..228 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 233..248 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 249..252 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 254..264 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 266..275 FT /evidence="ECO:0007829|PDB:7CEE" FT TURN 279..283 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 285..291 FT /evidence="ECO:0007829|PDB:7CEE" FT TURN 297..299 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 304..314 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 322..331 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 334..339 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 350..352 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 357..360 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 364..370 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 372..375 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 376..383 FT /evidence="ECO:0007829|PDB:7CEE" FT TURN 384..387 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 388..390 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 392..394 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 403..418 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 424..434 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 440..442 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 444..459 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 461..471 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 478..483 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 490..492 FT /evidence="ECO:0007829|PDB:7CEE" FT TURN 500..503 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 504..507 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 510..512 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 525..544 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 549..551 FT /evidence="ECO:0007829|PDB:7CEE" FT TURN 575..577 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 579..586 FT /evidence="ECO:0007829|PDB:7CEE" FT STRAND 588..592 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 595..602 FT /evidence="ECO:0007829|PDB:7CEE" FT HELIX 604..608 FT /evidence="ECO:0007829|PDB:7CEE" SQ SEQUENCE 825 AA; 91162 MW; CEF160C63E0A71A4 CRC64; MWLQPSLSLS PTPTVGRSLC LTLGFLSLVL RASTQAPAPT VNTHFGKLRG ARVPLPSEIL GPVDQYLGVP YAAPPIGEKR FLPPEPPPSW SGIRNATHFP PVCPQNIHTA VPEVMLPVWF TANLDIVATY IQEPNEDCLY LNVYVPTEDG SGAKKQGEDL ADNDGDEDED IRDSGAKPVM VYIHGGSYME GTGNMIDGSV LASYGNVIVI TLNYRVGVLG FLSTGDQAAK GNYGLLDQIQ ALRWVSENIA FFGGDPRRIT VFGSGIGASC VSLLTLSHHS EGLFQRAIIQ SGSALSSWAV NYQPVKYTSL LADKVGCNVL DTVDMVDCLR QKSAKELVEQ DIQPARYHVA FGPVIDGDVI PDDPEILMEQ GEFLNYDIML GVNQGEGLKF VEGVVDPEDG VSGTDFDYSV SNFVDNLYGY PEGKDTLRET IKFMYTDWAD RDNPETRRKT LVALFTDHQW VEPSVVTADL HARYGSPTYF YAFYHHCQSL MKPAWSDAAH GDEVPYVFGV PMVGPTDLFP CNFSKNDVML SAVVMTYWTN FAKTGDPNKP VPQDTKFIHT KANRFEEVAW SKYNPRDQLY LHIGLKPRVR DHYRATKVAF WKHLVPHLYN LHDMFHYTST TTKVPPPDTT HSSHITRRPN GKTWSTKRPA ISPAYSNENA PGSWNGDQDA GPLLVENPRD YSTELSVTIA VGASLLFLNV LAFAALYYRK DKRRQEPLRQ PSPQRGTGAP ELGTAPEEEL AALQLGPTHH ECEAGPPHDT LRLTALPDYT LTLRRSPDDI PLMTPNTITM IPNSLVGLQT LHPYNTFAAG FNSTGLPHSH STTRV //